MHC class I cross-presentation by dendritic cells counteracts viral immune evasion
- PMID:23189079
- PMCID: PMC3505839
- DOI: 10.3389/fimmu.2012.00348
MHC class I cross-presentation by dendritic cells counteracts viral immune evasion
Abstract
DCs very potently activate CD8(+) T cells specific for viral peptides bound to MHC class I molecules. However, many viruses have evolved immune evasion mechanisms, which inactivate infected DCs and might reduce priming of T cells. Then MHC class I cross-presentation of exogenous viral Ag by non-infected DCs may become crucial to assure CD8(+) T cell responses. Although many vital functions of infected DCs are inhibited in vitro by many different viruses, the contributions of cross-presentation to T cell immunity when confronted with viral immune inactivation in vivo has not been demonstrated up to now, and remains controversial. Here we show that priming of Herpes Simplex Virus (HSV)-, but not murine cytomegalovirus (mCMV)-specific CD8(+) T cells was severely reduced in mice with a DC-specific cross-presentation deficiency. In contrast, while CD8(+) T cell responses to mutant HSV, which lacks crucial inhibitory genes, also depended on CD8α(+) DCs, they were independent of cross-presentation. Therefore HSV-specific CTL-responses entirely depend on the CD8α(+) DC subset, which present via direct or cross-presentation mechanisms depending on the immune evasion equipment of virus. Our data establish the contribution of cross-presentation to counteract viral immune evasion mechanisms in some, but not all viruses.
Keywords: cross-priming; dendritic cells; immune evasion.
Figures




Similar articles
- The role of dendritic cells in immunity against primary herpes simplex virus infections.Bedoui S, Greyer M.Bedoui S, et al.Front Microbiol. 2014 Oct 21;5:533. doi: 10.3389/fmicb.2014.00533. eCollection 2014.Front Microbiol. 2014.PMID:25374562Free PMC article.Review.
- Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.Busche A, Jirmo AC, Welten SP, Zischke J, Noack J, Constabel H, Gatzke AK, Keyser KA, Arens R, Behrens GM, Messerle M.Busche A, et al.J Immunol. 2013 Mar 15;190(6):2767-77. doi: 10.4049/jimmunol.1200966. Epub 2013 Feb 6.J Immunol. 2013.PMID:23390296
- Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection.Munks MW, Pinto AK, Doom CM, Hill AB.Munks MW, et al.J Immunol. 2007 Jun 1;178(11):7235-41. doi: 10.4049/jimmunol.178.11.7235.J Immunol. 2007.PMID:17513772
- Effective Priming of Herpes Simplex Virus-Specific CD8+ T CellsIn Vivo Does Not Require Infected Dendritic Cells.Whitney PG, Makhlouf C, MacLeod B, Ma JZ, Gressier E, Greyer M, Hochheiser K, Bachem A, Zaid A, Voehringer D, Heath WR, Wagle MV, Parish I, Russell TA, Smith SA, Tscharke DC, Gebhardt T, Bedoui S.Whitney PG, et al.J Virol. 2018 Jan 17;92(3):e01508-17. doi: 10.1128/JVI.01508-17. Print 2018 Feb 1.J Virol. 2018.PMID:29142130Free PMC article.
- Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines.van Montfoort N, van der Aa E, Woltman AM.van Montfoort N, et al.Front Immunol. 2014 Apr 23;5:182. doi: 10.3389/fimmu.2014.00182. eCollection 2014.Front Immunol. 2014.PMID:24795724Free PMC article.Review.
Cited by
- T-cell immunity to human alphaherpesviruses.Ouwendijk WJ, Laing KJ, Verjans GM, Koelle DM.Ouwendijk WJ, et al.Curr Opin Virol. 2013 Aug;3(4):452-60. doi: 10.1016/j.coviro.2013.04.004. Epub 2013 May 8.Curr Opin Virol. 2013.PMID:23664660Free PMC article.Review.
- Cytomegalovirus immune evasion of myeloid lineage cells.Brinkmann MM, Dağ F, Hengel H, Messerle M, Kalinke U, Čičin-Šain L.Brinkmann MM, et al.Med Microbiol Immunol. 2015 Jun;204(3):367-82. doi: 10.1007/s00430-015-0403-4. Epub 2015 Mar 17.Med Microbiol Immunol. 2015.PMID:25776081Review.
- A VP22-Null HSV-1 Is Impaired in Inhibiting CD1d-Mediated Antigen Presentation.Liu J, Gallo RM, Duffy C, Brutkiewicz RR.Liu J, et al.Viral Immunol. 2016 Sep;29(7):409-16. doi: 10.1089/vim.2015.0145. Epub 2016 Jun 21.Viral Immunol. 2016.PMID:27327902Free PMC article.
- The role of dendritic cells in immunity against primary herpes simplex virus infections.Bedoui S, Greyer M.Bedoui S, et al.Front Microbiol. 2014 Oct 21;5:533. doi: 10.3389/fmicb.2014.00533. eCollection 2014.Front Microbiol. 2014.PMID:25374562Free PMC article.Review.
- An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge.Sicurella M, Nicoli F, Gallerani E, Volpi I, Berto E, Finessi V, Destro F, Manservigi R, Cafaro A, Ensoli B, Caputo A, Gavioli R, Marconi PC.Sicurella M, et al.PLoS One. 2014 Jul 17;9(7):e100844. doi: 10.1371/journal.pone.0100844. eCollection 2014.PLoS One. 2014.PMID:25033084Free PMC article.
References
- Belz G. T., Smith C. M., Eichner D., Shortman K., Karupiah G., Carbone F. R., et al. (2004a). Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172, 1996–2000 - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials